Investing.com -- Cassava Sciences stock plunged 13% in early New York trading on Monday after the company received a notification from the U.S. Food and Drug Administration (FDA) requesting additional ...

Investing.com -- Russian President Vladimir Putin has accepted some U.S. proposals to end the war in Ukraine while rejecting ...

Investing.com -- China has expressed willingness to strengthen cooperation with New Zealand on new energy vehicles and charging infrastructure, according to Chinese Vice Industry Minister Xin Guobin.

Investing.com -- Rivian Automotive is recalling 34,824 vehicles in the United States because of a damaged seat belt pretension cable that could fail to properly restrain the driver, the U.S. National ...

Investing.com -- Skanska has sold its Port7 office complex in Prague for approximately SEK 1.4 billion (€130 million) to AFI, the company announced Wednesday.

For Bayer, Morgan Stanley shifted its stance from Equal-weight to Overweight, framing the call as a valuation opportunity ...

Investing.com -- Copper prices have climbed to a new record high, exceeding $11,350 per ton on Wednesday. The price surge follows the largest increase in orders for the industrial metal since 2013.

Investing.com -- The European Central Bank (ECB) has urged Italy to reconsider a parliamentary amendment that declares the Bank of Italy’s gold reserves belong to the Italian people, according to a ...

Still not a member? Then this is your chance to subscribe at up to 55% off and secure access to the top picks for December. More than 250.000 investors trust InvestingPro when it comes to picking the ...

The company’s performance was marked by continued strength in its Digital and Lockers segments, while its Mail business remained weak, particularly in North America where mail equipment sales ...

Investing.com -- Deutsche Bank downgraded Whitbread Plc (LON:WTB), the Premier Inn hotel operator, to “hold” from “buy” and ...

Investing.com -- Cosmo Pharmaceuticals ’ shares jumped more than 20% on Wednesday after the Swiss drugmaker reported that two Phase III trials of its hair-loss treatment Breezula met their co-primary ...